Engineered “natural killer” cells could help fight cancer
A new study identifies genetic modifications that make these immune cells, known as CAR-NK cells, more effective at destroying cancer cells.
A new study identifies genetic modifications that make these immune cells, known as CAR-NK cells, more effective at destroying cancer cells.
The findings may offer a new way to help heal tissue damage from radiation or chemotherapy treatment.
MIT researchers have dramatically lowered the error rate of prime editing, a technique that holds potential for treating many genetic disorders.
A system conceived in Professor Michael Cima’s lab was approved by the Food and Drug Administration after positive results in patients.
New microparticles containing iron or iodine could be used to fortify food and beverages, to help fight malnutrition.
The new implant carries a reservoir of glucagon that can be stored under the skin and deployed during an emergency — with no injections needed.
Launched with a gift from the Biswas Family Foundation, the Biswas Postdoctoral Fellowship Program will support postdocs in health and life sciences.
The MIT-MGB Seed Program, launched with support from Analog Devices Inc., will fund joint research projects that advance technology and clinical research.
By delivering an HIV vaccine candidate along with two adjuvants, researchers showed they could generate many more HIV-targeting B cells in mice.
Researchers also found these effects can be reversed by treatment with an antioxidant.
The method could help predict whether immunotherapies will work in a patient or how a tumor will respond to drug treatment.
MIT engineers designed polymer microparticles that can deliver vaccines at predetermined times after injection.
The prestigious fellowship, which honors independence of thought, purposeful leadership, and civic mindset, funds graduate studies at Stanford University.
Their study yielded hundreds of “cryptic” peptides that are found only on pancreatic tumor cells and could be targeted by vaccines or engineered T cells.
The senior, majoring in electrical engineering and computer science, has participated in SuperUROP, NEET, MISTI GTL, and multiple labs focusing on biological EECS.